Skip to search.
 FTSE 100 Up 0.05%

Sangamo Biosciences Inc. (SGMO)

-NasdaqGS
6.33 Up 0.17(2.76%) 29 Jul 21:00
|After Hours: : 6.33 Up 0.00 (0.02%) 29 Jul 21:48
Prev Close:6.16
Open:6.13
Bid:5.30 x 200
Ask:6.45 x 500
1y Target Est:18.40
Beta:2.84986
Next Earnings Date: 3-Aug-16SGMO Earnings announcement
Day's Range:6.05 - 6.35
52wk Range:4.63 - 9.91
Volume:638,723
Avg Vol (3m):800,086
Market Cap:446.22m
P/E (ttm):N/A
EPS (ttm):-0.74
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

  • No Headlines available for SGMO at this time.

Comparison

Symbol% ChgMkt Cap
SGMOUp 2.76%446.22m
LLYDown 0.05%87.47b
AMGNUp 0.44%129.23b

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):14.48
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :-0.98
Quarterly EPS Est (Jun-16) :-0.24
Mean Recommendation*:1.4
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Sangamo BioSciences, Inc., a clinical stage biopharmaceutical company, focused on the research, development, and commercialization of engineered DNA-binding proteins for therapeutic genome editing and gene regulation. more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback